Bioanalytical Testing Services Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2030

  • Single User License $3500

Bioanalytical Testing Services Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2030

Status : April, 2021 | Pharmaceutical

Report Digest


Bioanalytical Testing Services Market: Overview

Bioanalytical testing services of various types are demanded by pharmaceutical companies in ensuring safety and efficacy of the drug molecules. Past few decades have seen the rise in popularity of bioanalytical method validation in ensuring reliability in the pharmacokinetic (PK) data. The role of the validation programs has been well established in the academia, industry, and regulatory agencies. Contract research organizations have been increasingly leaning on bioanalytical testing services for small and large molecules. Broadly, major service types can comprise cell-based assays, virology testing, method development, and optimization. Key techniques adopted by service providers are tandem mass spectrometry and nuclear magnetic resonance spectroscopy.

The study on the bioanalytical testing services market presents a critical assessment of the regulatory frameworks shaping the avenues for investments by pharmaceuticals in the market. Major trends in regulatory expectations in developed markets are scrutinized and the insights the report offers are backed by industry facts Technological advances and emerging dynamic of the life sciences industries that are expected to have long-ranging impacts on the market are analyzed. The researchers also strives to present analytics-drive assessment of current and emerging opportunities in various key service segments and the potential revenues streams in some of the developing and developed regions of the world.

Bioanalytical Testing Services Market: Key Trends

The growing pharmaceutical industry investment on outsourcing analytical testing is a key trend in the bioanalytical testing services market. A large proportion of the investments have been witnessed in the services that pertain to serology, immunogenicity, and neutralizing antibodies. The growing role of bioanalytical testing with good accuracy and precision, specificity and sensitivity in drug development programs has also shaped the contours of the market. Oncology is emerging as a markedly lucrative segment in the bioanalytical testing services market. Increasing focus of CROs on bioanalytical testing services for biosimilars and biologics has also spurred the demand. Advances in clinical pharmacology has helped boost the pace of new drug development. Hence, pre-clinical stages witness a growing demand for bioanalytical testing services. Rise in research and development of novel drug ingredients that are more disease centric has also boosted the demand in the bioanalytical testing services market.

However, there exist significant challenges in the use of bioanalysis techniques for macromolecules and small molecules. These are attracting pharma companies in bioanalytical testing services market who have been consolidating their biologic drugs pipelines. The concerns have spurred CROs and service providers to look for better methods, characteristically that are based on Good Laboratory Practice (GLP) and Good Clinical Practice (GCP).

Bioanalytical Testing Services Market: Competitive Dynamics and Key Developments

Technological advances in the platforms used for quantification of macromolecules are key to understanding of PK/PD relationship in clinical stages of drug development in bioanalytical testing services market. The adoption of automation technologies have enabled service providers obtain exposure-response data or relationships on several pharmacodynamics (PD) endpoints. Such developments have also set the tone for unveiling innovative services in the bioanalytical testing services market.

Some of the key players in the bioanalytical testing services market are;

  • Pace Analytical Services, LLC
  • Intertek group, Toxikon, Inc.
  • SGS SA
  • Syneos Health
  • ICON plc, Covance Inc.
  • PRA Health Sciences

Bioanalytical Testing Services Market: Regional Assessment

On the regional front, Asia Pacific has been emerging as the hotbed of opportunities for pharmaceutical companies. They are sourcing bioanalytical validation services in drug making by getting into deals and collaborations with the CROs in the region. The growing presence of CROs in Asia is one of the key stimulant for the rise in demand for various bioanalytical testing services. Rise in R&D in oncology drugs in North America has made the regional market an attractive one in the global bioanalytical testing services market.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?